Medacta Group SA 경쟁사
가격 내역 및 성능
| 과거 주가 | |
|---|---|
| 현재 주가 | CHF 113.60 |
| 52주 최고치 | CHF 135.00 |
| 52주 최저치 | CHF 107.80 |
| 베타 | 1.14 |
| 11개월 변경 | -8.83% |
| 3개월 변경 사항 | -7.49% |
| 1년 변경 사항 | 0.53% |
| 33년 변화 | -30.82% |
| 5년 변화 | 39.39% |
| IPO 이후 변화 | 18.21% |
최근 뉴스 및 업데이트
Is Medacta Group (VTX:MOVE) A Risky Investment?
Oct 14
Medacta Group SA (VTX:MOVE) Shares Could Be 32% Above Their Intrinsic Value Estimate
Sep 06What Does Medacta Group SA's (VTX:MOVE) Share Price Indicate?
Aug 21Medacta Group (VTX:MOVE) Is Reinvesting At Lower Rates Of Return
Aug 06Medacta Group SA's (VTX:MOVE) P/E Still Appears To Be Reasonable
Jun 20Recent updates
Is Medacta Group (VTX:MOVE) A Risky Investment?
Oct 14Medacta Group SA (VTX:MOVE) Shares Could Be 32% Above Their Intrinsic Value Estimate
Sep 06What Does Medacta Group SA's (VTX:MOVE) Share Price Indicate?
Aug 21Medacta Group (VTX:MOVE) Is Reinvesting At Lower Rates Of Return
Aug 06Medacta Group SA's (VTX:MOVE) P/E Still Appears To Be Reasonable
Jun 20We Discuss Why Medacta Group SA's (VTX:MOVE) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year
May 01Medacta Group (VTX:MOVE) Has A Pretty Healthy Balance Sheet
Apr 17Is Now An Opportune Moment To Examine Medacta Group SA (VTX:MOVE)?
Mar 29Does Medacta Group (VTX:MOVE) Deserve A Spot On Your Watchlist?
Feb 22Medacta Group (VTX:MOVE) Will Be Hoping To Turn Its Returns On Capital Around
Feb 07Getting In Cheap On Medacta Group SA (VTX:MOVE) Might Be Difficult
Dec 18Calculating The Intrinsic Value Of Medacta Group SA (VTX:MOVE)
Dec 04Is Now The Time To Look At Buying Medacta Group SA (VTX:MOVE)?
Nov 15Returns On Capital Signal Tricky Times Ahead For Medacta Group (VTX:MOVE)
Oct 30If EPS Growth Is Important To You, Medacta Group (VTX:MOVE) Presents An Opportunity
Oct 17Is Medacta Group (VTX:MOVE) Using Too Much Debt?
Sep 29Calculating The Intrinsic Value Of Medacta Group SA (VTX:MOVE)
Aug 11Is Now The Time To Look At Buying Medacta Group SA (VTX:MOVE)?
Jul 27Be Wary Of Medacta Group (VTX:MOVE) And Its Returns On Capital
Jul 03At CHF117, Is It Time To Put Medacta Group SA (VTX:MOVE) On Your Watch List?
Apr 28Is Medacta Group (VTX:MOVE) A Risky Investment?
Apr 08Is Now An Opportune Moment To Examine Medacta Group SA (VTX:MOVE)?
Dec 25Capital Allocation Trends At Medacta Group (VTX:MOVE) Aren't Ideal
Dec 09Does Medacta Group (VTX:MOVE) Have A Healthy Balance Sheet?
Nov 09Why Medacta Group SA (VTX:MOVE) Could Be Worth Watching
Sep 16The Returns On Capital At Medacta Group (VTX:MOVE) Don't Inspire Confidence
Aug 20Here's Why Medacta Group (VTX:MOVE) Has Caught The Eye Of Investors
Jul 02Should You Think About Buying Medacta Group SA (VTX:MOVE) Now?
May 28Medacta Group (VTX:MOVE) Is Reinvesting At Lower Rates Of Return
May 12These 4 Measures Indicate That Medacta Group (VTX:MOVE) Is Using Debt Reasonably Well
Mar 31Does Medacta Group (VTX:MOVE) Deserve A Spot On Your Watchlist?
Mar 17Capital Investments At Medacta Group (VTX:MOVE) Point To A Promising Future
Feb 07Should You Investigate Medacta Group SA (VTX:MOVE) At CHF133?
Dec 10Medacta Group (VTX:MOVE) Knows How To Allocate Capital
Nov 05Here's Why Medacta Group (VTX:MOVE) Can Manage Its Debt Responsibly
Sep 30Is It Too Late To Consider Buying Medacta Group SA (VTX:MOVE)?
Aug 26Medacta Group (VTX:MOVE) May Have Issues Allocating Its Capital
Jul 20Should You Investigate Medacta Group SA (VTX:MOVE) At CHF119?
May 19We Think Medacta Group (VTX:MOVE) Can Stay On Top Of Its Debt
Apr 05What You Need To Know About Medacta Group SA's (VTX:MOVE) Investor Composition
Mar 02Is Medacta Group SA's (VTX:MOVE) 7.6% ROE Better Than Average?
Feb 02The Medacta Group (VTX:MOVE) Share Price Has Gained 24% And Shareholders Are Hoping For More
Jan 12
Returns On Capital At Medacta Group (VTX:MOVE) Paint An Interesting Picture
Dec 21Should You Use Medacta Group's (VTX:MOVE) Statutory Earnings To Analyse It?
Dec 03주주 수익률
| MOVE | CH Medical Equipment | CH 마켓 | |
|---|---|---|---|
| 7D | -1.9% | -4.4% | -2.2% |
| 1Y | 0.5% | 19.7% | 11.2% |
수익률 대 산업: MOVE underperformed the Swiss Medical Equipment industry which returned 19.7% over the past year.
수익률 대 시장: MOVE underperformed the Swiss Market which returned 11.2% over the past year.
가격 변동성
| MOVE volatility | |
|---|---|
| MOVE Average Weekly Movement | 3.8% |
| Medical Equipment Industry Average Movement | 3.9% |
| Market Average Movement | 3.2% |
| 10% most volatile stocks in CH Market | 7.1% |
| 10% least volatile stocks in CH Market | 1.6% |
안정적인 주가: MOVE has not had significant price volatility in the past 3 months compared to the Swiss market.
시간에 따른 변동성: MOVE's weekly volatility (4%) has been stable over the past year.
회사 소개
| 설립 | 직원 | CEO | 웹사이트 |
|---|---|---|---|
| 1958 | 1,826 | Francesco Siccardi | www.medacta.com |
메닥타 그룹 SA는 유럽, 북미, 아시아 태평양 및 국제적으로 정형외과 및 신경외과 의료 기기를 개발, 제조 및 유통하는 회사입니다. 고관절, 무릎, 어깨, 관절 교체, 스포츠 의학 및 척추 시술에 사용할 수 있는 맞춤형 3D 계획 도구를 제공합니다. 1958년에 설립되어 스위스 카스텔 산 피에트로에 본사를 두고 있는 메닥타 그룹 SA.
Medacta Group SA 기본 사항 요약
| MOVE 기본 통계 | |
|---|---|
| 시가총액 | CHF 2.27b |
| 수익(TTM) | CHF 52.88m |
| 수익(TTM) | CHF 512.02m |
42.9x
P/E 비율4.4x
P/S 비율MOVE 주가가 과대평가되어 있나요?
공정 가치 및 가치 분석 보기수익 및 수익
| MOVE 손익 계산서(TTM) | |
|---|---|
| 수익 | €544.29m |
| 수익 비용 | €174.57m |
| 총 이익 | €369.72m |
| 기타 비용 | €313.51m |
| 수익 | €56.21m |
최근 보고된 수익
Jun 30, 2024
다음 수익 날짜
n/a
| 주당 순이익(EPS) | 2.82 |
| 총 마진 | 67.93% |
| 순이익 마진 | 10.33% |
| 부채/자본 비율 | 54.1% |
MOVE 의 장기적인 성과는 어땠나요?
과거 실적 및 비교 보기